Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single center, open-label, fixed sequence, two-period study to investigate the effect of memantine on pharmacokinetics, safety and tolerability of RO5313534 after single dose administration in healthy volunteers and the effect of RO5313534 on safety and tolerability of steady state memantine

Next Previous
Search
Trial Profile

A single center, open-label, fixed sequence, two-period study to investigate the effect of memantine on pharmacokinetics, safety and tolerability of RO5313534 after single dose administration in healthy volunteers and the effect of RO5313534 on safety and tolerability of steady state memantine

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RG 3487 (Primary) ; Memantine
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Sponsors Roche

    • Most Recent Events

    • 18 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 21 Mar 2011 Planned End Date changed from 1 Dec 2010 to 1 Mar 2011.
    • 15 Oct 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top